Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future

by Parisi, Alessandro, Porzio, Giampiero, Ficorella, Corrado
Published in Cancers (Basel) (2020)

Family history of cancer and DNA damage response genes: Two sides of the same coin?

by Cortellini, Alessio, Bersanelli, Melissa, Ficorella, Corrado, Buti, Sebastiano
Published in Thorac Cancer (2018)

A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients

by Cortellini, Alessio, Ficorella, Corrado, Crisci, Roberto, Divisi, Duilio
Published in J Thorac Dis (2020)

Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis

by Parisi, Alessandro, Cortellini, Alessio, Cannita, Katia, Bersanelli, Melissa, Ficorella, Corrado
Published in Case Rep Oncol Med (2019)

Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer

by Belfiglio, Maurizio, Fanizza, Caterina, Tinari, Nicola, Ficorella, Corrado, Iacobelli, Stefano, Natoli, Clara
Published 2011

“Vessels in the Storm”: Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer

by Angelucci, Adriano, Delle Monache, Simona, Cortellini, Alessio, Di Padova, Monica, Ficorella, Corrado
Published in Int J Mol Sci (2018)

Effectiveness and Safety of Intensive Triplet Chemotherapy Plus Bevacizumab, FIr-B/FOx, in Young-Elderly Metastatic Colorectal Cancer Patients

by Bruera, Gemma, Cannita, Katia, Giordano, Aldo Victor, Vicentini, Roberto, Ficorella, Corrado, Ricevuto, Enrico
Published 2013

Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, FIr-B/FOx, according to second-line treatment...

by BRUERA, GEMMA, CANNITA, KATIA, GIORDANO, ALDO VICTOR, VICENTINI, ROBERTO, FICORELLA, CORRADO, RICEVUTO, ENRICO
Published 2013

Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen

by BRUERA, GEMMA, CANNITA, KATIA, GIORDANO, ALDO VICTOR, VICENTINI, ROBERTO, FICORELLA, CORRADO, RICEVUTO, ENRICO
Published 2014

Rare bone toxicity associated with vismodegib

by Ciciarelli, Valeria, Cortellini, Alessio, Ventura, Alessandra, Gutiérrez García-Rodrigo, Carlota, Ficorella, Corrado, Fargnoli, Maria Concetta
Published in JAAD Case Rep (2020)

What Is Known about Theragnostic Strategies in Colorectal Cancer

by Parisi, Alessandro, Porzio, Giampiero, Pulcini, Fanny, Cannita, Katia, Ficorella, Corrado, Mattei, Vincenzo, Delle Monache, Simona
Published in Biomedicines (2021)

Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome

by Cortellini, Alessio, Parisi, Alessandro, Fargnoli, Maria Concetta, Cannita, Katia, Irelli, Azzurra, Porzio, Giampiero, Martinazzo, Claudio, Ficorella, Corrado
Published in Case Rep Oncol Med (2018)

Physical Exercise and Quality of Life in Breast Cancer Survivors

by VALENTI, Marco, PORZIO, Giampiero, AIELLI, Federica, VERNA, Lucilla, CANNITA, Katia, MANNO, Renato, MASEDU, Francesco, MARCHETTI, Paolo, FICORELLA, Corrado
Published 2008

Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes

by Zelli, Veronica, Compagnoni, Chiara, Capelli, Roberta, Cannita, Katia, Sidoni, Tina, Ficorella, Corrado, Capalbo, Carlo, Zazzeroni, Francesca, Tessitore, Alessandra, Alesse, Edoardo
Published in J Pers Med (2020)

Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)

by Bruera, Gemma, Cannita, Katia, Di Giacomo, Daniela, Lamy, Aude, Frébourg, Thierry, Sabourin, Jean Christophe, Tosi, Mario, Alesse, Edoardo, Ficorella, Corrado, Ricevuto, Enrico
Published 2013

Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice

by Bruera, Gemma, Cannita, Katia, Giordano, Aldo Victor, Manetta, Rosa, Vicentini, Roberto, Carducci, Sergio, Saltarelli, Patrizia, Iapadre, Nerio, Coletti, Gino, Ficorella, Corrado, Ricevuto, Enrico
Published 2014

Multicentric retrospective analysis of platinum‐pemetrexed regimens as first‐line therapy in non‐squamous non‐small cell lung cancer patients: A “snapshot” from clinical practice...

by Cortellini, Alessio, Gambale, Elisabetta, Cannita, Katia, Brocco, Davide, Parisi, Alessandro, Napoleoni, Luca, Masedu, Francesco, Irtelli, Luciana, De Tursi, Michele, Natoli, Clara, Ficorella, Corrado
Published in Thorac Cancer (2017)

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II st...

by Bruera, Gemma, Santomaggio, Alessandra, Cannita, Katia, Baldi, Paola Lanfiuti, Tudini, Marianna, De Galitiis, Federica, Mancini, Maria, Marchetti, Paolo, Antonucci, Adelmo, Ficorella, Corrado, Ricevuto, Enrico
Published 2010

Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation

by Napoleoni, Luca, Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Dal Mas, Antonella, Calvisi, Giuseppe, Venditti, Olga, Lanfiuti Baldi, Paola, Cocciolone, Valentina, Ricci, Alessandro, Ficorella, Corrado
Published in Bioengineering (Basel) (2019)

Dose-Dense Nonpegylated Liposomal Doxorubicin and Docetaxel Combination in Breast Cancer: Dose-Finding Study

by Ricevuto, Enrico, Cocciolone, Valentina, Mancini, Maria, Cannita, Katia, Romano, Silvio, Bruera, Gemma, Pelliccione, Michela, Adinolfi, Maria Ilaria, Ciccozzi, Antonietta, Bafile, Alberto, Penco, Maria, Ficorella, Corrado
Published in Oncologist (2015)